Three Stanford faculty named Fellows of the National Academy of Inventors
Stanford faculty members in engineering and medicine have been inducted into the National Academy of Inventors, which is the highest professional distinction awarded to academic inventors.
Stanford University faculty members Nick McKeown, Juan G. Santiago, and Joseph Wu are among the 169 distinguished inventors in the 2022 class of National Academy of Inventors (NAI) Fellows.
According to the NAI, the 2022 Fellow class hails from 110 research universities and governmental and nonprofit research institutions worldwide. They collectively hold over 5,000 issued U.S. patents.
Nick McKeown is the Kleiner Perkins, Mayfield, Sequoia Capital Professor in the School of Engineering. A professor of electrical engineering and of computer science, he researches techniques to improve the internet. Most of this work has focused on the architecture, design, analysis, and implementation of high-performance internet switches and routers. More recently, his interests have broadened to include network architecture, backbone network design, and congestion control; and how the internet might be redesigned if we were to start with a clean slate.
Juan G. Santiago is the Charles Lee Powell Foundation Professor in the School of Engineering. His research includes the development of microsystems for on-chip chemical and biochemical analysis, methods for DNA quantification and hybridization, and electric-field based deionization methods. A professor of mechanical engineering, he has served as an editor of several journals and has co-founded several companies in microfluidics. He has authored and co-authored over 200 archival publications and is a named inventor on 56 patents, 26 of which are currently licensed.
Joseph Wu is director of the Stanford Cardiovascular Institute; the Simon H. Stertzer, MD, Professor; and a professor of cardiovascular medicine and of radiology in the School of Medicine. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells. The main goals are to understand cardiovascular disease mechanisms, accelerate drug discovery, develop “clinical trial in a dish,” and implement precision medicine for cardiovascular patients. His lab uses a combination of genomics, stem cells, cellular and molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathological processes.
In total, 24 Stanford faculty have been elected to the NAI.